Capital Advantage’s Antares Pharma, Inc. ATRS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q1 | – | Sell |
-13,000
| Closed | -$45K | – | 46 |
|
2021
Q4 | $45K | Hold |
13,000
| – | – | 0.01% | 40 |
|
2021
Q3 | $47K | Hold |
13,000
| – | – | 0.01% | 38 |
|
2021
Q2 | $57K | Buy |
+13,000
| New | +$57K | 0.01% | 40 |
|
2021
Q1 | – | Sell |
-16,000
| Closed | -$61K | – | 114 |
|
2020
Q4 | $61K | Hold |
16,000
| – | – | 0.02% | 104 |
|
2020
Q3 | $51K | Hold |
16,000
| – | – | 0.02% | 92 |
|
2020
Q2 | $44K | Sell |
16,000
-8,000
| -33% | -$22K | 0.02% | 90 |
|
2020
Q1 | $66K | Hold |
24,000
| – | – | 0.03% | 87 |
|
2019
Q4 | $96K | Sell |
24,000
-10,000
| -29% | -$40K | 0.03% | 94 |
|
2019
Q3 | $114K | Buy |
+34,000
| New | +$114K | 0.04% | 88 |
|
2019
Q1 | $103K | Hold |
34,000
| – | – | 0.04% | 77 |
|
2018
Q4 | $92K | Hold |
34,000
| – | – | 0.03% | 71 |
|
2018
Q3 | $114K | Hold |
34,000
| – | – | 0.03% | 81 |
|
2018
Q2 | $88K | Hold |
34,000
| – | – | 0.02% | 81 |
|
2018
Q1 | $75K | Hold |
34,000
| – | – | 0.02% | 73 |
|
2017
Q4 | $68K | Hold |
34,000
| – | – | 0.02% | 78 |
|
2017
Q3 | $110K | Buy |
+34,000
| New | +$110K | 0.03% | 81 |
|